Pharmaceuticals, Biotechnology and Life Sciences
LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported financial results for the…
ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that George A. Scangos, Ph.D. has notified the company of his decision…
– Conference Call Today at 4:30 p.m. ET – SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$XFOR–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…
– Results Surpass FDA-Agreed Efficacy Threshold – SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today reports an update on clinical data from…
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the cancellation of its planned March 3 presentation and webcast at the…
How B.C. is leading the fight VANCOUVER, British Columbia–(BUSINESS WIRE)–#2019LSBCAWARDS–LifeSciences BC is hosting a Blakes Breakfast Speaking Event on COVID-19,…
DUBLIN–(BUSINESS WIRE)–The “Flow Cytometry Market by Product and Solution (Consumables, Instrument, Software, Service), Technology (Cell-based, Bead-based), Application (Cancer, Immunology, Hematology),…
DUBLIN–(BUSINESS WIRE)–The “Latest Development, Product Innovations and Treatments for Diabetes” report has been added to ResearchAndMarkets.com’s offering. This report includes:…